MetaCap

Revelation Biosciences Insider Trades

NASDAQ: REVBHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.7599-0.0201 (-2.58%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
0 · $0
Sales
0 · $0
Shares bought / sold
0 / 0
Net activity
Net buying $0

Revelation Biosciences insider activity

Over the last 12 months, Revelation Biosciences insiders reported 24 transactions on SEC Form 4: 0 open-market purchases and 0 sales. The most recent filing shows Rolke James (Chief Executive Officer) reporting a transaction in 208,076 shares on Aug 17, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put REVB's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

REVB insider transactions

Revelation Biosciences insider transactions
DateInsiderTypeSharesValueFiling
Aug 17, 2026CARVER JENNIFERDirectorAward32,011—Form 4
Aug 17, 2026ROPER JESSDirectorAward32,011—Form 4
Aug 17, 2026Zygmont Chester Stanley IIIChief Financial OfficerGift208,073—Form 4
Aug 17, 2026Zygmont Chester Stanley IIIChief Financial OfficerGift208,073—Form 4
Aug 17, 2026Zygmont Chester Stanley IIIChief Financial OfficerAward208,073—Form 4
Aug 17, 2026Chawla Lakhmir SDirectorAward32,011—Form 4
Aug 17, 2026Rolke JamesChief Executive OfficerAward208,076—Form 4
Apr 30, 2026Zygmont Chester Stanley IIIChief Financial OfficerTax withholding13,285$14.61KForm 4
Apr 30, 2026Rolke JamesChief Executive OfficerTax withholding10,115$11.43KForm 4
Feb 4, 2026Zygmont Chester Stanley IIIChief Financial OfficerTax withholding13,100$21.61KForm 4
Feb 3, 2026CARVER JENNIFERDirectorTax withholding1,661$3.11KForm 4
Feb 3, 2026Chawla Lakhmir SDirectorTax withholding2,261$4.18KForm 4
Feb 3, 2026ROPER JESSDirectorTax withholding1,591$2.94KForm 4
Feb 3, 2026Rolke JamesChief Executive OfficerTax withholding8,521$15.85KForm 4
Jan 8, 2026Chawla Lakhmir SDirectorAward41,981$37.78KForm 4
Jan 8, 2026ROPER JESSDirectorAward41,981$37.78KForm 4
Jan 8, 2026CARVER JENNIFERDirectorAward41,981$37.78KForm 4
Jan 8, 2026Zygmont Chester Stanley IIIChief Financial OfficerAward78,145$70.33KForm 4
Jan 8, 2026Rolke JamesChief Executive OfficerAward532,829$479.55KForm 4
Oct 29, 2025ROPER JESSDirectorAward15,625$20.00KForm 4
Oct 29, 2025Zygmont Chester Stanley IIIChief Financial OfficerAward390,614$499.99KForm 4
Oct 29, 2025CARVER JENNIFERDirectorAward15,625$20.00KForm 4
Oct 29, 2025Rolke JamesChief Executive OfficerAward390,614$499.99KForm 4
Oct 29, 2025Chawla Lakhmir SDirectorAward15,625$20.00KForm 4
Feb 11, 2025TIDMARSH GEORGE FDirectorAward181$700.47Form 4
Feb 11, 2025ROPER JESSDirectorAward181$700.47Form 4
Feb 11, 2025CARVER JENNIFERDirectorAward181$700.47Form 4
Feb 11, 2025Chawla Lakhmir SDirectorAward181$700.47Form 4
Feb 11, 2025Zygmont Chester Stanley IIIChief Financial OfficerAward15,048$58.24KForm 4
Feb 11, 2025Rolke JamesChief Executive OfficerAward30,095$116.47KForm 4
Dec 8, 2023TIDMARSH GEORGE FDirectorSale27,771$14.44KForm 4
Oct 16, 2023TIDMARSH GEORGE FDirectorSale10,957$7.24KForm 4
Oct 16, 2023TIDMARSH GEORGE FDirectorSale1,845$1.20KForm 4
Sep 28, 2023TIDMARSH GEORGE FDirectorSale1,429$986.01Form 4
Sep 18, 2023TIDMARSH GEORGE FDirectorSale4,000$2.96KForm 4
Sep 15, 2023TIDMARSH GEORGE FDirectorSale9,500$6.93KForm 4
Sep 14, 2023TIDMARSH GEORGE FDirectorSale12,000$9.00KForm 4
Apr 18, 2023TIDMARSH GEORGE FDirectorBuy25,000$29.00KForm 4
Apr 17, 2023TIDMARSH GEORGE FDirectorBuy26,500$30.74KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related